73 results
Page 3 of 4
8-K
EX-99.1
z6yy7kmk
26 Oct 20
Cogent Biosciences Appoints
7:13am
DEFM14A
sa7v 1gnoj
9 Oct 20
Proxy related to merger
4:44pm
8-K
EX-99.1
e9qm8 padjw05vhne
5 Oct 20
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
9:08am
8-K
EX-99.1
sfoie64o
3 Sep 20
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
fsthokv7
11 Aug 20
Unum Therapeutics Reports Second Quarter 2020
5:02pm
8-K
EX-99.1
ht4cmyyj
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-2.1
yz8kj1ey3yv g99z
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-10.1
aixdo
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-99.1
dmzwo5sxfni
11 May 20
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates
4:38pm
8-K
EX-99.1
6o5cz3piqq9w
26 Mar 20
Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates
7:39am
424B5
5hv68
20 Mar 20
Prospectus supplement for primary offering
8:26am
8-K
EX-99.1
pjhaoloj
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-99.1
kgz30am8g3
2 Mar 20
Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cancers
8:50am